Ophthalmologic Evaluation of Patients With Obesity and Metabolic Syndrome Before and After Bariatric Surgery
1 other identifier
observational
200
1 country
1
Brief Summary
The aim of this study was to investigate the pathogenic role of obesity on blinding eye diseases in a population of severely obese patients with no history of eye diseases, and to verify whether weight loss induced by bariatric surgery may have a protective effect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 17, 2021
CompletedFirst Submitted
Initial submission to the registry
June 10, 2021
CompletedFirst Posted
Study publicly available on registry
June 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedJune 23, 2021
June 1, 2021
2 years
June 10, 2021
June 18, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
optical coherence tomography
12 months
Eligibility Criteria
1. Patients with BMI≥32.5Kg/m2Or patients with BMI27.5-32.5Kg/m2, combined with metabolic diseases; 2. Subjects understand the purpose of the clinical study and are willing, able and committed to return to the study center for all clinical study visits and to complete all study procedures.
You may qualify if:
- Patients with BMI≥32.5Kg/m2;
- patients with BMI27.5-32.5Kg/m2, combined with metabolic diseases;
You may not qualify if:
- Patients with pre-existing ocular diseases or visual alterations were excluded to avoid confounding factors related to pre-existing retinal pathology, independent from obesity per se.
- Patients with dementia, Parkinson's disease, Alzheimer's disease, multiple sclerosis or other severe neurological diseases were also excluded since ophthalmologic parameters may be altered in these conditions.
- Patients with lens opacities that made impossible the posterior segment examination, or with a refractive error \> +5 or \<-8 diopters spherical equivalent were also excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- XiaoYong Liulead
Study Sites (1)
The First Affiliated Hospital of Jinan University
Guangzhou, Guangdong, 510630, China
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Deputy chief physician of opthalmology, The First Affiliated Hospital of Jinan University
Study Record Dates
First Submitted
June 10, 2021
First Posted
June 15, 2021
Study Start
May 17, 2021
Primary Completion
April 30, 2023
Study Completion
April 30, 2023
Last Updated
June 23, 2021
Record last verified: 2021-06